Additionally, pre-S deletion, T1753V mutation in BCP, and C1653T mutation in box-α of Enhancer II have been reported to be related with increased risk of HCC in several reports [8,9,10,11,12]. Here, OPN1SW is linked to hepatocellular carcinoma.